News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

TG Therapeutics, Inc. (MHA) to Present at Lazard Capital Markets 9th Annual Healthcare Conference


11/13/2012 8:12:12 AM

NEW YORK, Nov. 13, 2012 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (OTCBB:TGTX), an innovative, clinical-stage biopharmaceutical company focused on the acquisition, development and commercialization of medically important pharmaceutical products for the treatment of cancer and other underserved therapeutic needs, today announced that Michael Weiss, the Company's Executive Chairman and Interim Chief Executive Officer, will be presenting at the Lazard Capital Markets 9th Annual Healthcare Conference, being held at the Pierre Hotel in New York City. Mr. Weiss' presentation is scheduled to take place on Wednesday November 14, 2012 at 1:30 PM ET. A webcast of this presentation will be available at www.tgtxinc.com on the Events page under the Investors & Media Tab.

Read at GlobeNewswire

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES